Drug
Elsulfavirine clinical trials
Also written VM-1500, Elpida® and VM-1500A.
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2018 (3)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Viriom (11)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses elsulfavirine is read from its arms, and is right about nine times in ten.
Testing it · 11
- Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy SubjectsCompletedPhase 1ViriomNCT05165550Written as Elsulfavirine
- Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other DrugsCompletedPhase 1ViriomNCT03709355Written as Elpida®
- Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy VolunteersCompletedPhase 1ViriomNCT05204121Written as Elpida
- Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA®CompletedPhase 1/2ViriomNCT05163535Written as VM-1500A-LAI
- Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral DrugsCompletedPhase 1ViriomNCT03706898Written as Elpida®
- Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy SubjectsCompletedPhase 1ViriomNCT03706911Written as VM-1500A-LAI
- An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy VolunteersCompletedPhase 1ViriomNCT05148754Written as Elsulfavirine
- Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy VolunteersStatus unknownPhase 1ViriomNCT03730311Written as Elpida
- Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500CompletedPhase 1ViriomNCT02489487Written as VM-1500
- Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral TherapyCompletedPhase 2/3ViriomNCT02489461Written as VM-1500
- Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy VolunteersCompletedPhase 1ViriomNCT02489435Written as VM-1500
As the comparator · 1 — what is tested is compared with elsulfavirine
Codes
What other systems call elsulfavirine · ClinicalTrials.gg INT001679
- MeSH (NLM) C000718630elsulfavirineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) ZC4CGO0RUGELSULFAVIRINEConfirmed FDA, NLM, Wikidata
- Wikidata Q110782362elsulfavirineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169939ElsulfavirineOne source FDA
- DrugBank DB14929One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000718630 | elsulfavirine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | ZC4CGO0RUG | ELSULFAVIRINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q110782362 | elsulfavirine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169939 | Elsulfavirine | One source FDA |
| DrugBank | DB14929 | — | One source Wikidata |
Also registered as elsulfavirine sodium (UNII HKK2U3V1DT).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.